| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 23 |
| 1 | FUROSEMIDE | 20 |
| 2 | METFORMIN | 19 |
| 3 | METFORMIN ER 500 MG | 19 |
| 4 | METFORMIN ER 750 MG | 19 |
| 5 | VALSARTAN | 17 |
| 6 | PREDNISOLONE | 16 |
| 7 | PREDNISOLONE ORAL | 16 |
| 8 | PREDNISOLONE ORAL SOLUTION | 16 |
| 9 | FOLIC ACID | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 1 | PAMABROM | 1 | 0.0027 |
| 2 | COCAINE HYDROCHLORIDE | 1 | 0.0026 |
| 3 | ISOPROTERENOL HYDROCHLORIDE | 1 | 0.0023 |
| 4 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 5 | BUPROPION HYDROBROMIDE | 1 | 0.0017 |
| 6 | FOSNETUPITANT AND PALONOSETRON | 2 | 0.0017 |
| 7 | NETUPITANT AND PALONOSETRON | 2 | 0.0017 |
| 8 | ERYTHROMYCIN ETHYLSUCCINATE | 1 | 0.0016 |
| 9 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 48 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 2 | Loop Diuretic [EPC] | 23 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 18 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| 5 | Vitamin C [EPC] | 16 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 15 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 15 |
| 8 | Platinum-based Drug [EPC] | 15 |
| 9 | Vitamin B12 [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cannabinoid [EPC] | 3 | 0.0004 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 2 | Nitrate Vasodilator [EPC] | 13 | 0.0001 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 15 | 0.0001 |
| 6 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Oxazolidinone Antibacterial [EPC] | 3 | 0.0001 |
| 8 | Polyene Antifungal [EPC] | 4 | 0.0001 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |